Malaria vaccine for children first to achieve key efficacy target
SHARE A malaria drug being tested in Africa has become the first drug to reach the efficacy rate required by the World Health Organisation. Researchers from the University of Oxford found the drug was effective in young children, even when taken at a lower dose. The results of the trial of potential malaria vaccine R21/Matrix-M, carried out in Burkina Faso’s Nanoro region, were published in The Lancet on Friday. Scientists say if the drug receives approval, hundreds of millions of doses could be available to help stop the threat of malaria. Read More “These new results support our high e...
Source: thenationalnews.com